Ideaya plans to submit an investigational new drug application next year for IDE034, a B7H3/PTK7 topo-I-payload bispecific antibody-drug conjugate.

The carbonated beverage from Mexico has been reinvigorated by the multinational Coca-Cola Company, who will start distribution in Texas and California.

Ideaya Biosciences (IDYA) announced the selection of IDE034, a B7H3/PTK7 topo-I-payload BsADC, as a development candidate and the exercise of ...

Shop our holiday picks for the best gifts for travelers, frequent fliers and globetrotters, chosen by the experts at Engadget ...

Ideaya Biosciences has decided to go ahead with its plans to grab a bispecific antibody-drug conjugate (ADC) from Biocytogen, exercising an option to pick up a preclinical asset from the Chinese ...

The South Yorkshire indie five-piece returned to their hometown and captivated the crowd with a superb, memorable performance ...